VIPERA: Viral Intra-Patient Evolution Reporting and Analysis

Miguel Álvarez-Herrera,Jordi Sevilla,Paula Ruiz-Rodriguez,Andrea Vergara,Jordi Vila,Pablo Cano-Jiménez,Fernando González-Candelas,Iñaki Comas,Mireia Coscollá
DOI: https://doi.org/10.1093/ve/veae018
IF: 5.614
2024-01-01
Virus Evolution
Abstract:Abstract Viral mutations within patients nurture the adaptive potential of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during chronic infections, which are a potential source of variants of concern. However, there is no integrated framework for the evolutionary analysis of intra-patient SARS-CoV-2 serial samples. Herein, we describe Viral Intra-Patient Evolution Reporting and Analysis (VIPERA), a new software that integrates the evaluation of the intra-patient ancestry of SARS-CoV-2 sequences with the analysis of evolutionary trajectories of serial sequences from the same viral infection. We have validated it using positive and negative control datasets and have successfully applied it to a new case, which revealed population dynamics and evidence of adaptive evolution. VIPERA is available under a free software license at https://github.com/PathoGenOmics-Lab/VIPERA.
virology
What problem does this paper attempt to address?
The paper aims to address the following issues: 1. **Viral Evolution Analysis in Chronic Infections**: During chronic SARS-CoV-2 infections, viral mutations can enhance its adaptive potential and may become sources of variants of concern (VOC). However, there is currently a lack of an integrated framework to analyze the evolutionary trajectories of SARS-CoV-2 sequences within patients. 2. **Development of the VIPERA Software Tool**: To fill this gap, researchers have developed VIPERA (Viral Intra-Patient Evolution Reporting and Analysis), a new software tool designed to integrate and assess the ancestral relationships of SARS-CoV-2 sequences within patients and analyze the evolutionary trajectories of consecutive samples from the same viral infection. 3. **Validation and Application Case**: Researchers validated the effectiveness of VIPERA using positive and negative control datasets and successfully applied it to a new case, revealing evidence of population dynamics and adaptive evolution within the patient. Overall, VIPERA aims to provide a user-friendly workflow to easily identify and study intra-patient evolution in chronic SARS-CoV-2 infections, thereby helping researchers better understand how these chronic infections generate new variants.